Death of volunteer in clinical trial in Brazil of COVID-19 vaccine developed by AstraZeneca and Oxford University

Oxford University said in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.” Brazilian health authority Anvisa said that the trial would continue.

Reuters Health